Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers use magnetic attraction to improve stents, reduce blood clot risk

03.11.2006
Mayo Clinic heart researchers have devised a new strategy to improve the effectiveness and safety of heart stents, which are used to open narrowed blood vessels and have been the recent subject of clotting concerns. Their novel approach is based on magnetizing healing cells from the patient's blood so the cells are quickly drawn to magnetically coated stents.

The research report appears in the Nov. 7 issue of the Journal of the American College of Cardiology (http://content.onlinejacc.org/). The Mayo team describes encouraging results from preclinical testing.

In the study, the cells were extracted from blood, and tiny iron-based paramagnetic particles were placed within the cells. Each stent was implanted through a tube (catheter) threaded through the blood vessels. Researchers then introduced the iron-tagged cells back into the blood vessel to test how well the magnetized stents captured the cells.

Because the healing cells -- also known as endothelial progenitor cells derived from circulating blood -- naturally fight blood clot formation, their swift magnetically guided arrival to the stent may reduce the chances of blood clot formation by lining the site fully and quickly, Mayo researchers say.

Results show a sixfold to 30-fold improvement in the magnetized stents' performance in capturing the healing endothelial cells, compared to the standard stents' ability to do so.

"The ability to rapidly coat implanted devices with living cells could accelerate local tissue healing and thereby reduce the risk of blood clot formation," says cardiologist Gurpreet Sandhu, M.D., Ph.D., lead investigator. "Our approach of magnetic cell targeting is the next generation of strategies for improving the safety of stents -- and it appears that magnetic forces may provide an elegant solution for cell capture. Additionally, this new magnetic targeting technology can be adapted to develop new cell-, gene- and drug-based treatments for cancer and other human diseases."

Dr. Sandhu adds that, while encouraging, the method is still experimental and not ready to be used on human patients. Researchers are refining their approach, including developing new biomaterials.

Significance of the Mayo Research

"Many people are currently concerned about the risk of blood clots associated in a small percentage of patients with the use of drug-eluting stents," says cardiologist and cardiac researcher Robert Simari, M.D., who co-authored the paper. "Our approach holds the potential to overcome the limitations of the current drug-eluting stent technology because we address the basic conditions of clot formation. One of the reasons clots can form in drug-eluting stent patients is that the area surrounding the stent is not relined fully or quickly enough with the cells in the body, called endothelial cells, that naturally fight blood clots. Our system delivers endothelial cells right where they need to be, rapidly, with the potential for limiting clot formation."

How It Works

Multiple steps led to the development of the new Mayo magnetic cell targeting stent system. For example, the researchers had to devise:

o a way to successfully get endothelial cells derived from blood and grown in lab dishes to live and proliferate when tagged with tiny amounts of magnetically responsive material known as iron-based paramagnetic microspheres.

o specially fabricated stainless steel stents coated with magnetic materials that demonstrated excellent ability to capture the magnetically tagged endothelial cells.

Traci Klein | EurekAlert!
Further information:
http://www.mayo.edu

More articles from Health and Medicine:

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

nachricht NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>